New York, NY -- (SBWIRE) -- 12/04/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Novavax, Inc (NASDAQ:NVAX), Juniper Networks, Inc (NYSE:JNPR), Federal National Mortgage Association (OTCBB:FNMA)
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) showed a volume of 1.56 million shares by the end of last trade whereas the average volume of the stock remained 1.75 million shares. The stock opened the session at $1.15 but then moved to $1.11. Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrine therapy. The Company’s pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. The development priorities in oncology are the completion of Phase 3 trials with perifosine in colorectal cancer (CRC) and in multiple myeloma (MM), as well as the further advancement of AEZS-108,
Is AEZS a Solid Investment at These Levels? Read This Report For Details
Novavax, Inc (NASDAQ:NVAX) opened the session at $3.87 and closed the session at $3.98. The stock showed a positive performance of 3.38% in previous trading session. Traded with volume of 15.05 million shares in the prior session and the average volume of the stock remained 3.19 million shares. Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines. The Company’s technology platform is based on recombinant vaccine technology that includes the virus-like particles (VLPs). The Company's vaccine candidates are genetically engineered three-dimensional nanostructures, which incorporate immunologically important recombinant proteins.
For How Long NVAX will fight for Profitability? Read This Trend Analysis report
Juniper Networks, Inc (NYSE:JNPR) opened the session at $20.23 and closed the session at $20.37. The stock showed a positive performance of 0.30% in previous trading session. Traded with volume of 10.44 million shares in the prior session and the average volume of the stock remained 8.07 million shares. The beta of the stock remained 1.93. Juniper Networks, Inc. (Juniper Networks) designs, develops, and sells products and services that together provide its customers with network infrastructure. It operates in two segments: Infrastructure and Service Layer Technologies (SLT). The Company’s Infrastructure segment primarily offers routing and switching products that are used to control and direct network traffic from the core, through the edge, aggregation,
Why Should Investors Buy JNPR After The Recent Gain? Just Go Here and Find Out
Federal National Mortgage Association (OTCBB:FNMA) the stock decreased -2.84% and finished the session at $2.74. Traded with volume of 10.69 million shares in the prior session and the average volume of the stock remained 8.99 million shares. The beta of the stock remained 3.44. Federal National Mortgage Association Fannie Mae is a government-sponsored enterprise (GSE) chartered by the United States Congress to support liquidity and stability in the secondary mortgage market, where mortgage-related assets are purchased and sold. The Company’s activities include providing market liquidity by securitizing mortgage loans originated by lenders in the primary mortgage market into Fannie Mae mortgage-backed securities (Fannie Mae MBS),
Will FNMA Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)